Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy)

NCT05593614 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Peripheral Neuropathy

Interventions

DRUG: ATX01 10%
DRUG: ATX01 15%
DRUG: Placebo

Sponsor

AlgoTherapeutix